Conference Overview
The Premier Destination for Cardiometabolic Innovation
The Annual Cardiometabolic Health Congress made its return to Boston in 2022 and was a huge success! Register now to access the On Demand recordings and join the foremost leaders in cardiometabolic medicine for an actionable examination on the latest research and updates in the field.
17th Annual
Cardiometabolic Health
Congress
CMHC Faculty
CMHC Chairpersons
Senior Planning Committee
Faculty
On Demand Agenda
2022 CMHC On Demand |
|---|
Cardiometabolic Health in Older Adults: Gaps, Best Practices and Expert Perspectives Opening Remarks Robert H. Eckel, MD Healthy Aging and Cardiometabolic Risk: Overview and Perspectives Donald M. Lloyd-Jones, MD Assessing Frailty in Clinical Practice Jeff D. Williamson, MD Maintaining a Healthy Lifestyle in Older Adults: Recommendations to Improve Nutrition and Physical Activity Dennis T. Villareal, MD Older Adults and Hypertension: Beyond the Guidelines Dena Rifkin, MD Lipid Lowering Therapy in Older Adults: Guidelines, Gaps, and Emerging Options Kenneth Feingold, MD Deprescribing in Older Adults with Type 2 Diabetes: Strategies and Perspectives Marie E. McDonnell, MD Polypharmacy and Drug-Drug Interactions in Older Adults with Cardiovascular Disease Joseph Saseen, PharmD Expert Panel Discussion and Audience Q&A Moderator: Robert H. Eckel, MD Panelists: Kenneth Feingold, MD; Donald Lloyd-Jones, MD; Dena Rifkin, MD; Jeff D. Williamson, MD; Marie E. McDonnell, MD; Dennis T. Villareal, MD |
FDA Update and Late Breaking Trials and Keynote Opening Remarks & FDA Update and Late Breaking Trials Chair: Christie M. Ballantyne, MD Presenters: Robert H. Eckel, MD; Anne L. Peters, MD; George L. Bakris, MD;Keith C. Ferdinand, MD; Deepak L. Bhatt, MD, MPH Keynote Address: Therapeutic Inertia in Cardiometabolic Disease Louis Philipson, MD, PhD |
Obesity & Lifestyle Opening Remarks Robert H. Eckel, MD Physical Activity & Cardiometabolic Health: Benefits and Perspectives Jill Kanaley, PhD Healthy Eating Patterns: Updates from Recent Guidelines Amy Hess-Fischl, MS, RD, LDN, BC-ADM, CDCES Pre-Obesity: Intervening Early to Decrease Future Complications Michelle Look, MD Dispelling Common Myths About Obesity Fatima Cody Stanford, MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS Making Sense of the Evolving Treatment Landscape in Obesity Louis J. Aronne, MD Challenging Obesity Cases & Panel Discussion Moderator: Robert H. Eckel, MD Panelists: Louis J. Aronne, MD; Jill Kanaley, PhD; Michelle Look, MD; Fatima Cody Stanford, MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS; Amy Hess-Fischl, MS, RD, LDN, BC-ADM, CDCES |
Opening Remarks & FDA Update and Late Breaking Trials Chair: Christie M. Ballantyne, MD Presenters: Robert H. Eckel, MD; Anne L. Peters, MD; George L. Bakris, MD;Keith C. Ferdinand, MD; Deepak L. Bhatt, MD, MPH Keynote Address: Therapeutic Inertia in Cardiometabolic Disease Louis Philipson, MD, PhD |
Dyslipidemia/Atherosclerosis/Thrombosis Opening Remarks Christie M. Ballantyne, MD The Role of Imaging Modalities in Atherosclerosis & Cardiovascular Risk Stratification Michael Blaha, MD Defining and Quantifying Residual ASCVD Risk in 2022 Erin D. Michos, MD The Evolving Story of Lipoprotein (a) Patrick Moriarty, MD The Changing Treatment Landscape in Dysplipidemia: New and Emerging Agents Pam R. Taub, MD Challenging Lipid Management Cases & Panel Discussion Moderator: Christie M. Ballantyne, MD Panelists: Michael Blaha, MD; Robert H. Eckel, MD; Pam R. Taub, MD; Patrick Moriarty, MD; Erin D. Michos, MD |
Diabetes Management Opening Remarks Anne L. Peters, MD Nutrition and Diets in Diabetes: Quantity vs. Quality Alison B. Evert, MS, RDN, CDCES Why Should We Use CGM in Patients with Type 2 Diabetes? Assessing the Evidence and Practical Pearls for Integration Supported by an educational grant from Dexcom. Irl B. Hirsch, MD Emerging Treatment Options for Diabetes Juan P. Frias, MD Challenges with Insulin Management for Diabetes Irl B. Hirsch, MD Challenging Diabetes Management Cases & Panel Discussion Moderator: Anne L. Peters, MD Panelists: Juan P. Frias, MD; Vanita R. Aroda, MD; Irl B. Hirsch, MD; Alison B. Evert, MS, RDN, CDCES |
CardioRenal Opening Remarks George L. Bakris, MD Update of Cardiorenal Risk Reduction: The advent of Pillar Therapy in Kidney Disease George L. Bakris, MD Challenges and Advances in Heart Failure Management: How to Individualize Therapy Accordingly Alanna A. Morris, MD Novel and Emerging Therapies in Heart Failure Ileana L Piña, MD Non-Steroidal MRAs: DKD and Beyond Rajiv Agarwal, MD Importance of Assessment and Potential Treatment of Masked Hypertension Raymond R. Townsend, MD Therapeutic Inertia and Resistant Hypertension: Strategies to Achieve Treatment Goals Challenging Cardiorenal Cases & Expert Panel Discussion Moderator: George L. Bakris, MD Panel: Rajiv Agarwal, MD; Brent Egan, MD; Alanna A. Morris, MD; Ileana L Piña, MD; Raymond R. Townsend, MD |
2022 CMHC On Demand
1
Cardiometabolic Health in Older Adults: Gaps, Best Practices and Expert Perspectives
Opening Remarks
Robert H. Eckel, MD
Healthy Aging and Cardiometabolic Risk: Overview and Perspectives
Donald M. Lloyd-Jones, MD
Assessing Frailty in Clinical Practice
Jeff D. Williamson, MD
Maintaining a Healthy Lifestyle in Older Adults: Recommendations to Improve Nutrition and Physical Activity
Dennis T. Villareal, MD
Older Adults and Hypertension: Beyond the Guidelines
Dena Rifkin, MD
Lipid Lowering Therapy in Older Adults: Guidelines, Gaps, and Emerging Options
Kenneth Feingold, MD
Deprescribing in Older Adults with Type 2 Diabetes: Strategies and Perspectives
Marie E. McDonnell, MD
Polypharmacy and Drug-Drug Interactions in Older Adults with Cardiovascular
Joseph Saseen, PharmD
Expert Panel Discussion and Audience Q&A
Moderator: Robert H. Eckel, MD
Panelists: Kenneth Feingold, MD; Donald Lloyd-Jones, MD; Dena Rifkin, MD; Jeff D. Williamson, MD; Marie E. McDonnell, MD; Dennis T. Villareal, MD
2
FDA Update and Late Breaking Trials and Keynote
Opening Remarks & FDA Update and Late Breaking Trials
Chair: Christie M. Ballantyne
Presenters: Robert H. Eckel, MD; Anne L. Peters, MD; George L. Bakris, MD; Keith C. Ferdinand, MD; Deepak L. Bhatt, MD, MPH
Keynote Address: Therapeutic Inertia in Cardiometabolic Disease
Louis Philipson, MD, PhD
3
Obesity & Lifestyle
Opening Remarks
Robert H. Eckel, MD
Physical Activity & Cardiometabolic Health: Benefits and Perspectives
Jill Kanaley, PhD
Healthy Eating Patterns: Updates from Recent Guidelines
Amy Hess-Fischl, MS, RD, LDN, BC-ADM, CDCES
Pre-Obesity: Intervening Early to Decrease Future Complications
Michelle Look, MD
Dispelling Common Myths About Obesity
Fatima Cody Stanford, MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS
Making Sense of the Evolving Treatment Landscape in Obesity
Louis J. Aronne, MD
Challenging Obesity Cases & Panel Discussion
Moderator: Robert H. Eckel, MD
Panelists: Louis J. Aronne, MD; Jill Kanaley, PhD; Michelle Look, MD; Fatima Cody Stanford, MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS; Amy Hess-Fischl, MS, RD, LDN, BC-ADM, CDCES
4
Dyslipidemia/Atherosclerosis/Thrombosis
Opening Remarks
Christie M. Ballantyne, MD
The Role of Imaging Modalities in Atherosclerosis & Cardiovascular Risk Stratification
Michael Blaha, MD
Defining and Quantifying Residual ASCVD Risk in 2022
Erin D. Michos, MD
The Evolving Story of Lipoprotein (a)
Patrick Moriarty, MD
The Changing Treatment Landscape in Dysplipidemia: New and Emerging Agents
Pam R. Taub, MD
Challenging Lipid Management Cases & Panel Discussion
Moderator: Christie M. Ballantyne, MD
Panelists: Michael Blaha, MD; Robert H. Eckel, MD; Pam R. Taub, MD; Patrick Moriarty, MD; Erin D. Michos, MD
5
Diabetes Management
Opening Remarks
Anne L. Peters, MD Nutrition and Diets in Diabetes: Quantity vs. Quality
Alison B. Evert, MS, RDN, CDCES
Why Should We Use CGM in Patients with Type 2 Diabetes? Assessing the Evidence and Practical Pearls for Integration
Supported by an educational grant from Dexcom.
Irl B.Hirsch, MD
Emerging Treatment Options for Diabetes
Juan P. Frias, MD
Challenges with Insulin Management for Diabetes
Irl B. Hirsch, MD
Challenging Diabetes Management Cases & Panel Discussion
Moderator: Anne L. Peters, MD
Panelists: Juan P. Frias, MD; Vanita R. Aroda, MD; Irl B. Hirsch, MD; Alison B. Evert, MS, RDN, CDCES
6
CardioRenal
Opening Remarks
George L. Bakris, MD
Update of Cardiorenal Risk Reduction: The advent of Pillar Therapy in Kidney Disease
George L. Bakris, MD
Challenges and Advances in Heart Failure Management: How to Individualize Therapy Accordingly
Alanna A. Morris, MD
Novel and Emerging Therapies in Heart Failure
Ileana L Piña, MD
Non-Steroidal MRAs: DKD and Beyond
Rajiv Agarwal, MD
Importance of Assessment and Potential Treatment of Masked Hypertension
Raymond R. Townsend, MD
Therapeutic Inertia and Resistant Hypertension: Strategies to Achieve Treatment Goals
Brent Egan, MD
Challenging Cardiorenal Cases & Expert Panel Discussion
Moderator: George L. Bakris, MD
Panelists: Rajiv Agarwal, MD; Brent Egan, MD; Alanna A. Morris, MD; Ileana L Piña, MD; Raymond R. Townsend, MD
On Demand Registration
Thank you to all of our 2022 sponsors and media/association partners!
Thank you to all of our 2022 sponsors and media/association partners!
